Abera Bioscience at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Abera Bioscience takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its sessions centre on its outer membrane vesicle (OMV) platform for mucosal vaccines. One follows how the OMV vaccine technology is being carried from the lab into clinical use, together with NorthX Biologics.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Develops mucosal vaccines against serious infectious diseases on a proprietary platform of outer membrane vesicles (OMVs). | Booth Exhibiting (no floor booth listed) Talk Mon Oct 19 10:30 Talk Wed Oct 21 10:30 From Innovation to Impact: Translating OMV Vaccine Technology into Clinical Reality How a developer and a contract manufacturer take vaccines made from outer membrane vesicles, tiny bacterial bubbles, from research toward clinical trials. |
Instantly find 20 buyers from Abera Bioscience
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction